Houshang Moayeri
Hematology & Oncology · Huntington Beach, CANPI 1508814716
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 84 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 9.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,297 and has fallen 95.7% since, to $56 in 2021. That places this record below the midpoint for hematology & oncology clinicians in CA, where the typical reported total is $3,371.
Across 84 payments — averaging $19.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$157
- Genentech USA, Inc.$133
- Johnson & Johnson$128
- Pharmacyclics LLC, An Abbvie Company$111
- AstraZeneca$88
- Lilly USA, LLC$85
- plus $972 from 30 others
What the payments were for
- Food & beverage$1,65199%
- Education$211%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 9 | $157 |
| Genentech USA, Inc. | 7 | $133 |
| Johnson & Johnson | 5 | $128 |
| Pharmacyclics LLC, An Abbvie Company | 5 | $111 |
| AstraZeneca(2 entities) | 4 | $88 |
| Lilly USA, LLC | 5 | $85 |
| Amgen | 3 | $75 |
| Novartis | 4 | $71 |
| Exelixis Inc. | 2 | $65 |
| Eisai Inc. | 3 | $61 |
| Foundation Medicine, Inc. | 1 | $61 |
| Bayer | 3 | $58 |
| Bristol Myers Squibb | 2 | $48 |
| E.r. Squibb & Sons, L.L.C. | 3 | $43 |
| AbbVie | 2 | $39 |
| Tolmar Pharmaceuticals, Inc. | 2 | $36 |
| Octapharma USA, Inc. | 1 | $31 |
| Tersera Therapeutics LLC | 2 | $30 |
| Pfizer | 2 | $28 |
| Partner Therapeutics, Inc. | 2 | $28 |
| Boehringer Ingelheim | 2 | $26 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Seagen Inc. | 1 | $23 |
| Gilead | 1 | $23 |
| Dendreon Pharmaceuticals LLC | 1 | $22 |
| AMAG Pharmaceuticals, Inc. | 1 | $21 |
| CSL Behring | 1 | $18 |
| Astellas Pharma US Inc | 1 | $18 |
| Dova Pharmaceuticals | 1 | $17 |
| Shionogi Inc | 1 | $17 |
| Array Biopharma Inc | 1 | $15 |
| Clovis Oncology, Inc. | 1 | $14 |
| Rigel Pharmaceuticals, Inc. | 1 | $13 |
| Sanofi | 1 | $12 |
| Incyte Corporation | 1 | $11 |
How this compares
$1,672 in reported general payments places this provider in the 40th percentile of 1,363 hematology & oncology providers in California.
Other hematology & oncology in Huntington Beach
- Dennis SlamonLos Angeles$3.1M
- Sandra HorningStanford$2.5M
- Mohammadbagher ZiariCorona$2.5M
- George YaghmourLos Angeles$1.9M
- Robert VescioWest Hollywood$1.1M
- Kevin KellyLos Angeles$894K
- Johnny ChangEncino$884K
- Nitin RohatgiSacramento$814K
- Omid HamidSanta Monica$809K
- Catherine CoombsOrange$786K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.